ArticleFrontiers in immunology2025

Unveiling the IL-1β/CXCL2 axis: a shared therapeutic target in periodontitis and inflammatory bowel disease.

Zhongyi Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.